Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Galectin Therapeutics News

    3,50 $ +6,38% +0,21 $
    In : 3,2633 € | 25.04.24 22:00:04 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1JV3R
    ISIN: US3632252025
    US-Symbol: GALT
    Typ: Aktie

    Galectin Therapeutics News

    12.10.22 - PR Newswire
    Thinking about buying stock in Autolus Therapeutics, Uber, Galectin Therapeutics, El Pollo LoCo, or BioNano Genomics?
    Thinking about buying stock in Autolus Therapeutics, Uber, Galectin Therapeutics, El Pollo LoCo, or BioNano Genomics? PR Newswire
    14.04.22 - PR Newswire
    Thinking about buying stock in Galectin Therapeutics, Dolphin Entertainment, Rite Aid, Protalix Biotherapeutics, or Aterian?
    Thinking about buying stock in Galectin Therapeutics, Dolphin Entertainment, Rite Aid, Protalix Biotherapeutics, or Aterian? PR Newswire
    14.07.21 - PR Newswire
    Thinking about buying stock in Powerbridge Technologies, Galectin Therapeutics, Clene, Velodyne Lidar, or CleanSpark?
    Thinking about buying stock in Powerbridge Technologies, Galectin Therapeutics, Clene, Velodyne Lidar, or CleanSpark? PR Newswire
    09.07.21 - PR Newswire
    Thinking about buying stock in Galectin Therapeutics, Hall of Fame Resort & Entertainment, PubMatic, 360 DigiTech, or Aslan Pharmaceuticals?
    Thinking about buying stock in Galectin Therapeutics, Hall of Fame Resort & Entertainment, PubMatic, 360 DigiTech, or Aslan Pharmaceuticals? PR Newswire
    19.04.21 - PR Newswire
    Thinking about buying stock in Westport Fuel Systems, Galectin Therapeutics, eMagin Corp, Aemetis, or BioLineRx?
    Thinking about buying stock in Westport Fuel Systems, Galectin Therapeutics, eMagin Corp, Aemetis, or BioLineRx? PR Newswire
    14.04.21 - PR Newswire
    Thinking about buying stock in Galectin Therapeutics, Moleculin Biotech, Microvision, Nikola Corp, or Ardelyx?
    Thinking about buying stock in Galectin Therapeutics, Moleculin Biotech, Microvision, Nikola Corp, or Ardelyx? PR Newswire
    18.12.17 - PR Newswire
    SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Galectin Therapeutics Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
    SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Galectin Therapeutics Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
    30.01.17 - PR Newswire
    Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd
    Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd PR Newswire
    30.01.17 - PR Newswire
    Galectin Therapeutics to Webcast, Live, at VirtualInvestorConferences.com on February 2
    Galectin Therapeutics to Webcast, Live, at VirtualInvestorConferences.com on February 2 PR Newswire
    28.08.14 - PR Newswire
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of ...
    12.08.14 - PR Newswire
    Law Offices of Marc S. Henzel Announces Securities Class Action Periods
    Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
    08.08.14 - PR Newswire
    Lifshitz & Miller Law Firm Announces Investigation of Cobalt International Energy, Inc., DreamWorks Animation SKG, Inc., Galectin Therapeutics, Inc., Impax Laboratories, Inc., Peoples Federal Banc
    Lifshitz & Miller Law Firm Announces Investigation of Cobalt International Energy, Inc., DreamWorks Animation SKG, Inc., Galectin Therapeutics, Inc., Impax Laboratories, Inc., ...
    06.08.14 - PR Newswire
    Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Galectin Therapeutics Inc.
    Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Galectin Therapeutics Inc. PR Newswire
    01.08.14 - PR Newswire
    Attention Galectin Therapeutics Inc. Investors: Galectin Misled Investors According to a Recently Filed Class Action
    Attention Galectin Therapeutics Inc. Investors: Galectin Misled Investors According to a Recently Filed Class Action PR Newswire
    31.07.14 - PR Newswire
    Harwood Feffer LLP Announces Investigation of Galectin Therapeutics Inc.
    Harwood Feffer LLP Announces Investigation of Galectin Therapeutics Inc. PR Newswire
    30.07.14 - PR Newswire
    Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Galectin Therapeutics, Inc.
    Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Galectin Therapeutics, Inc. PR Newswire
    29.07.14 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics, Inc. - GALT
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics, Inc. - GALT PR Newswire
    24.07.13 - PR Newswire
    Galectin Therapeutics Announces First Patient Dosed in Phase 1 Trial of GR-MD-02, a Potential First-in-Class Treatment for Fatty Liver Disease with Advanced Fibrosis
    Galectin Therapeutics Announces First Patient Dosed in Phase 1 Trial of GR-MD-02, a Potential First-​in-Class Treatment for Fatty Liver Disease with Advanced Fibrosis PR Newswire
    01.07.13 - PR Newswire
    Galectin Therapeutics Submits Fast Track Application to FDA for GR-MD-02 in Treatment of Fatty Liver Disease with Advanced Fibrosis
    Galectin Therapeutics Submits Fast Track Application to FDA for GR-MD-02 in Treatment of Fatty Liver Disease with Advanced Fibrosis PR Newswire
    21.06.13 - PR Newswire
    Galectin Therapeutics Names Industry-Veteran Jack W. Callicutt Chief Financial Officer
    Galectin Therapeutics Names Industry-​Veteran Jack W. Callicutt Chief Financial Officer PR Newswire

    Newssuche

    Videos

    25.04.24 +21,95%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »